United States · Funded startup
6 rounds we have observed, with the 4 investors named in them. Every figure came from a named source, and where the company reported a raise to the SEC itself, that is shown beside it.
Funding summaryUpdated 26 Oct 2026
$92Mraised across 6 rounds since 2007, from 6 sources
Each circle is a round, placed by date and sized by amount. The line above is the running total.
No investor was named in the report.
From a historical funding recordSEC filing: $25M sold, first sale Apr 2014
No investor was named in the report.
From a historical funding recordSEC filing: $25M sold, first sale Apr 2014
Scale Venture Partners
Domain Associates
Essex Woodlands Healthcare PartnersReported by fiercebiotech.comSEC filing: $21M sold, first sale Jul 2009
No investor was named in the report.
From a historical funding recordSEC filing: $3.0M sold, first sale Apr 2009
Reported by venturebeat.com
The busiest backers across the latest rounds. A filled square is a round they joined; a dark one, a round they led.
Essex Woodlands Healthcare PartnersSynergy Life Science PartnerScale Venture PartnersDomain AssociatesMissing a round, or an investor who was in one? Tell us.
Oraya Therapeutics's investors include Essex Woodlands Healthcare Partners, Synergy Life Science Partner, Scale Venture Partners and Domain Associates.
Oraya Therapeutics has raised $92M across 6 rounds since 2007.
Oraya Therapeutics's most recent round was a Grant of $215K in Aug 2014.
Oraya Therapeutics's largest round on record is $42M (Series C), in Jul 2009.
Oraya Therapeutics's first round on record, in Jun 2007, was backed by Essex Woodlands Healthcare Partners.
Oraya Therapeutics's latest named round is a Grant, in Aug 2014.
Oraya Therapeutics is based in the United States.
In the same sector, and raised in the last eighteen months.
Search every investor by what they have actually funded, then narrow to your stage and market. Free.
United States · 
